NQO2
Ribosyldihydronicotinamide dehydrogenase [quinone]
Also known as: DHQV, DIA6, NMOR2, NQO2_HUMAN, QR2
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P16083
- Gene
- NQO2
- Ensembl
- ENSG00000124588
- Chromosome
- 6
- Canonical length
- 231 aa
- Protein class
- Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Cytosol
- Quaternary structure
- Homodimer
OverviewNCBI Gene
This gene encodes a member of the thioredoxin family of enzymes. It is a cytosolic and ubiquitously expressed flavoprotein that catalyzes the two-electron reduction of quinone substrates and uses dihydronicotinamide riboside as a reducing coenzyme. Mutations in this gene have been associated with neurodegenerative diseases and several cancers. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Mar 2014]
Canonical amino-acid sequenceUniProt
231 residues, UniProt reviewed canonical sequence.
>P16083|NQO2
1 MAGKKVLIVY AHQEPKSFNG SLKNVAVDEL SRQGCTVTVS DLYAMNLEPR ATDKDITGTL
61 SNPEVFNYGV ETHEAYKQRS LASDITDEQK KVREADLVIF QFPLYWFSVP AILKGWMDRV
121 LCQGFAFDIP GFYDSGLLQG KLALLSVTTG GTAEMYTKTG VNGDSRYFLW PLQHGTLHFC
181 GFKVLAPQIS FAPEIASEEE RKGMVAAWSQ RLQTIWKEEP IPCTAHWHFG QLocalizationUniProt · AlphaFold · HPA
Whether an antibody against NQO2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.26
- Highest tissue expression
- 177 nTPM
Expression across tissuesHPA
Tissue
- kidney: 177 nTPM
- tongue: 136 nTPM
- liver: 116 nTPM
- skeletal muscle: 114 nTPM
- adrenal gland: 109 nTPM
- choroid plexus: 106 nTPM
Single-cell type
- neutrophils: 279 nCPM
- hepatocytes: 268 nCPM
- proximal tubule cells: 191 nCPM
- neutrophil progenitors: 125 nCPM
- enterocytes: 117 nCPM
- hofbauer cells: 108 nCPM
Immune cell
- neutrophil: 241 nTPM
- classical monocyte: 92 nTPM
- intermediate monocyte: 64 nTPM
- myeloid DC: 62 nTPM
- non-classical monocyte: 61 nTPM
- eosinophil: 53 nTPM
Brain region
- choroid plexus: 101 nTPM
- cerebral cortex: 98 nTPM
- pons: 94 nTPM
- cerebellum: 93 nTPM
- medulla oblongata: 78 nTPM
- white matter: 74 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.48
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.47
- DepMap mean gene effect
- 0.17
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- quinone catabolic process
Molecular functions
- chloride ion binding
- electron transfer activity
- FAD binding
- NAD(P)H dehydrogenase (quinone) activity
- oxidoreductase activity
- oxidoreductase activity, acting on other nitrogenous compounds as donors
- protein homodimerization activity
- zinc ion binding
- dihydronicotinamide riboside quinone reductase activity
- melatonin binding
- resveratrol binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads NQO2 as an antibody target. Whether an autoantibody or antibody against NQO2 could matter depends on whether native NQO2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
NQO2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label NQO2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...